TheraRadar

Padagis

Pre-Approval PRO BETA
🔴

Stale Activity

No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 2/7/2023

21
Total Trials
21
Phase 3
0
Phase 2
0
Recruiting
315
Score

Pipeline by Phase

Phase 3
21
Phase 2
Phase 1

Therapeutic Focus

Rosacea Acne Glaucoma, Open-Angle Ocular Hypertension Crohn's Disease

Clinical Trials (21)

NCT04944290 Phase 3 COMPLETED

To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes

Started: 5/28/2021

NCT05763082 Phase 3 COMPLETED

Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis

Started: 2/7/2023

NCT04024072 Phase 3 COMPLETED

To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes

Started: 6/24/2019

NCT04155203 Phase 3 COMPLETED

To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions

Started: 10/15/2019

NCT01453946 Phase 3 COMPLETED

Safety and Maintenance Study of Entocort for Children With Crohn's Disease

Started: 12/1/2011

NCT01444092 Phase 3 COMPLETED

Safety Study of Entocort for Children With Crohn's Disease

Started: 11/1/2011

NCT02800148 Phase 3 COMPLETED

Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face

Started: 11/1/2016

NCT03393494 Phase 3 COMPLETED

Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face

Started: 12/13/2017

NCT02515305 Phase 3 COMPLETED

Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris

Started: 7/1/2015

NCT03352323 Phase 3 COMPLETED

An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea

Started: 10/18/2017

NCT02385318 Phase 3 COMPLETED

To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis

Started: 2/1/2015

NCT02770365 Phase 3 COMPLETED

Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy

Started: 5/1/2016

NCT02795117 Phase 3 COMPLETED

Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea

Started: 5/1/2016

NCT02459795 Phase 3 COMPLETED

To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis

Started: 5/1/2015

NCT02525549 Phase 3 COMPLETED

Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris

Started: 12/1/2011

NCT02230696 Phase 3 COMPLETED

Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis

Started: 8/1/2014

NCT01796665 Phase 3 COMPLETED

A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris

Started: 2/1/2012

NCT02265913 Phase 3 COMPLETED

Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis

Started: 10/6/2014

NCT02385240 Phase 3 COMPLETED

Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of Rosacea

Started: 3/1/2015

NCT01673659 Phase 3 COMPLETED

A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)

Started: 8/1/2012

NCT01138514 Phase 3 COMPLETED

Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels

Started: 10/1/2009

Drug Candidates

Brinzolamide/brimonidine ophthalmic suspension Simbrinza 0.2%/1% Ophthalmic Suspension roflumilast cream 0.3% Zoryve Brinzolamide 1% ophthalmic suspension Azopt 1% Ophthalmic Suspension Mupirocin Calcium Entocort Azelaic acid foam Adapalene and Benzoyl Peroxide Topical Gel
Activity Status: Stale
Last Trial Started: 2/7/2023
Last Trial Ended: 8/8/2023
Trials (12 months): 0
Completed Trials: 21
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.